vs

Side-by-side financial comparison of Corpay (CPAY) and Xylem Inc. (XYL). Click either name above to swap in a different company.

Xylem Inc. is the larger business by last-quarter revenue ($2.1B vs $1.2B, roughly 1.7× Corpay). Corpay runs the higher net margin — 21.2% vs 8.9%, a 12.3% gap on every dollar of revenue. On growth, Corpay posted the faster year-over-year revenue change (20.7% vs 2.7%). Over the past eight quarters, Corpay's revenue compounded faster (15.5% CAGR vs -1.0%).

Corpay, Inc., headquartered in Atlanta, Georgia, provides payments and spend management systems and services that control expense-related purchasing and payment processes. The company focuses on vehicle-related expenses, lodging expenses, and corporate payments.

Xylem is one of the two types of transport tissue in vascular plants, the other being phloem; both of these are part of the vascular bundle. The basic function of the xylem is to transport water upward from the roots to parts of the plants such as stems and leaves, but it also transports nutrients. The word xylem is derived from the Ancient Greek word ξύλον (xúlon), meaning "wood"; the best-known xylem tissue is wood, though it is found throughout a plant.

CPAY vs XYL — Head-to-Head

Bigger by revenue
XYL
XYL
1.7× larger
XYL
$2.1B
$1.2B
CPAY
Growing faster (revenue YoY)
CPAY
CPAY
+18.0% gap
CPAY
20.7%
2.7%
XYL
Higher net margin
CPAY
CPAY
12.3% more per $
CPAY
21.2%
8.9%
XYL
Faster 2-yr revenue CAGR
CPAY
CPAY
Annualised
CPAY
15.5%
-1.0%
XYL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CPAY
CPAY
XYL
XYL
Revenue
$1.2B
$2.1B
Net Profit
$264.5M
$189.0M
Gross Margin
37.8%
Operating Margin
45.2%
11.5%
Net Margin
21.2%
8.9%
Revenue YoY
20.7%
2.7%
Net Profit YoY
7.5%
13.2%
EPS (diluted)
$3.74
$0.79

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPAY
CPAY
XYL
XYL
Q1 26
$2.1B
Q4 25
$1.2B
$2.4B
Q3 25
$1.2B
$2.3B
Q2 25
$1.1B
$2.3B
Q1 25
$1.0B
$2.1B
Q4 24
$1.0B
$2.3B
Q3 24
$1.0B
$2.1B
Q2 24
$975.7M
$2.2B
Net Profit
CPAY
CPAY
XYL
XYL
Q1 26
$189.0M
Q4 25
$264.5M
$335.0M
Q3 25
$277.9M
$227.0M
Q2 25
$284.2M
$226.0M
Q1 25
$243.2M
$169.0M
Q4 24
$246.0M
$326.0M
Q3 24
$276.4M
$217.0M
Q2 24
$251.6M
$194.0M
Gross Margin
CPAY
CPAY
XYL
XYL
Q1 26
37.8%
Q4 25
38.9%
Q3 25
38.9%
Q2 25
38.8%
Q1 25
37.1%
Q4 24
38.0%
Q3 24
37.3%
Q2 24
37.8%
Operating Margin
CPAY
CPAY
XYL
XYL
Q1 26
11.5%
Q4 25
45.2%
14.7%
Q3 25
44.6%
14.7%
Q2 25
43.5%
13.3%
Q1 25
42.5%
11.2%
Q4 24
47.2%
11.8%
Q3 24
45.5%
13.3%
Q2 24
44.4%
11.7%
Net Margin
CPAY
CPAY
XYL
XYL
Q1 26
8.9%
Q4 25
21.2%
14.0%
Q3 25
23.7%
10.0%
Q2 25
25.8%
9.8%
Q1 25
24.2%
8.2%
Q4 24
23.8%
14.5%
Q3 24
26.9%
10.3%
Q2 24
25.8%
8.9%
EPS (diluted)
CPAY
CPAY
XYL
XYL
Q1 26
$0.79
Q4 25
$3.74
$1.37
Q3 25
$3.91
$0.93
Q2 25
$3.98
$0.93
Q1 25
$3.40
$0.69
Q4 24
$3.43
$1.33
Q3 24
$3.90
$0.89
Q2 24
$3.52
$0.80

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPAY
CPAY
XYL
XYL
Cash + ST InvestmentsLiquidity on hand
$2.4B
$808.0M
Total DebtLower is stronger
$10.0B
$1.9B
Stockholders' EquityBook value
$3.9B
$11.0B
Total Assets
$26.4B
$17.0B
Debt / EquityLower = less leverage
2.58×
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPAY
CPAY
XYL
XYL
Q1 26
$808.0M
Q4 25
$2.4B
$1.5B
Q3 25
$2.0B
$1.2B
Q2 25
$2.2B
$1.2B
Q1 25
$1.6B
$1.1B
Q4 24
$1.6B
$1.1B
Q3 24
$1.3B
$989.0M
Q2 24
$1.4B
$815.0M
Total Debt
CPAY
CPAY
XYL
XYL
Q1 26
$1.9B
Q4 25
$10.0B
$2.0B
Q3 25
$8.1B
$2.0B
Q2 25
$8.1B
$2.0B
Q1 25
$8.2B
$2.0B
Q4 24
$8.0B
$2.0B
Q3 24
Q2 24
Stockholders' Equity
CPAY
CPAY
XYL
XYL
Q1 26
$11.0B
Q4 25
$3.9B
$11.5B
Q3 25
$4.1B
$11.2B
Q2 25
$3.9B
$11.1B
Q1 25
$3.5B
$10.8B
Q4 24
$3.1B
$10.6B
Q3 24
$3.1B
$10.6B
Q2 24
$2.8B
$10.3B
Total Assets
CPAY
CPAY
XYL
XYL
Q1 26
$17.0B
Q4 25
$26.4B
$17.6B
Q3 25
$19.7B
$17.3B
Q2 25
$20.4B
$17.2B
Q1 25
$18.5B
$16.6B
Q4 24
$18.0B
$16.5B
Q3 24
$17.6B
$16.0B
Q2 24
$16.2B
$15.8B
Debt / Equity
CPAY
CPAY
XYL
XYL
Q1 26
0.18×
Q4 25
2.58×
0.17×
Q3 25
1.99×
0.18×
Q2 25
2.07×
0.18×
Q1 25
2.37×
0.19×
Q4 24
2.56×
0.19×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPAY
CPAY
XYL
XYL
Operating Cash FlowLast quarter
$812.7M
Free Cash FlowOCF − Capex
$760.3M
FCF MarginFCF / Revenue
60.9%
Capex IntensityCapex / Revenue
4.2%
4.2%
Cash ConversionOCF / Net Profit
3.07×
TTM Free Cash FlowTrailing 4 quarters
$1.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPAY
CPAY
XYL
XYL
Q1 26
Q4 25
$812.7M
$543.0M
Q3 25
$-378.9M
$360.0M
Q2 25
$1.1B
$305.0M
Q1 25
$-74.2M
$33.0M
Q4 24
$648.7M
$575.0M
Q3 24
$400.8M
$311.0M
Q2 24
$540.9M
$288.0M
Free Cash Flow
CPAY
CPAY
XYL
XYL
Q1 26
Q4 25
$760.3M
$460.0M
Q3 25
$-429.8M
$281.0M
Q2 25
$1.1B
$207.0M
Q1 25
$-118.9M
$-38.0M
Q4 24
$604.6M
$475.0M
Q3 24
$355.0M
$237.0M
Q2 24
$496.8M
$215.0M
FCF Margin
CPAY
CPAY
XYL
XYL
Q1 26
Q4 25
60.9%
19.2%
Q3 25
-36.7%
12.4%
Q2 25
98.7%
9.0%
Q1 25
-11.8%
-1.8%
Q4 24
58.4%
21.1%
Q3 24
34.5%
11.3%
Q2 24
50.9%
9.9%
Capex Intensity
CPAY
CPAY
XYL
XYL
Q1 26
4.2%
Q4 25
4.2%
3.5%
Q3 25
4.3%
3.5%
Q2 25
4.8%
4.3%
Q1 25
4.5%
3.4%
Q4 24
4.3%
4.4%
Q3 24
4.4%
3.5%
Q2 24
4.5%
3.4%
Cash Conversion
CPAY
CPAY
XYL
XYL
Q1 26
Q4 25
3.07×
1.62×
Q3 25
-1.36×
1.59×
Q2 25
4.01×
1.35×
Q1 25
-0.30×
0.20×
Q4 24
2.64×
1.76×
Q3 24
1.45×
1.43×
Q2 24
2.15×
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPAY
CPAY

Vehicle Payments$572.9M46%
Corporate Payments$480.8M39%
Lodging Payments$112.5M9%
Other Operating Segments$82.1M7%

XYL
XYL

Revenue from products$1.8B83%
Revenue from services$368.0M17%

Related Comparisons